<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0385">
 <label>77</label>
 <element-citation publication-type="other" id="rf0370">
  <person-group person-group-type="author">
   <name>
    <surname>APEIRON Biologics AG</surname>
   </name>
  </person-group>
  <article-title>APEIRON Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19</article-title>
  <ext-link ext-link-type="uri" xlink:href="https://www.apeiron-biologics.com/wp-content/uploads/2020/04/20200402_APEIRON_Phase-2-EU-trial_APN01_ENG.pdf" id="ir0100" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.apeiron-biologics.com/wp-content/uploads/2020/04/20200402_APEIRON_Phase-2-EU-trial_APN01_ENG.pdf</ext-link>
 </element-citation>
</ref>
